First Affiliated Hospital of Zhejiang University
358
106
121
61
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.0%
7 terminated/withdrawn out of 358 trials
89.7%
+3.2% vs industry average
8%
29 trials in Phase 3/4
0%
0 of 61 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (358)
Healthy Participants Randomized, Double-blind, Placebo-controlled, Phase Ⅰ
Role: lead
A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone Deacetylase Inhibitor) in People Living With HIV
Role: lead
Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer
Role: lead
Effects of Opioid Drugs on Sleep and Emotion in Patients With Moderate to Severe Cancer Pain
Role: lead
rTMS-tACS Stimulation on Improving Cognitive Function in Bipolar Disorder
Role: lead
Neuronavigation rTMS to Improve Depressive Episodes of Bipolar Disorder in Adolescent
Role: lead
The Efficacy and Safety of Task-state-based Temporal Interference Stimulation (TI) in the Treatment of Patients With Depression
Role: lead
Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity
Role: lead
Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder
Role: lead
Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression
Role: lead
Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder
Role: lead
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
Inulin-Spirulina Co-intervention for Insomnia Disorder
Role: lead
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
Role: collaborator
Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage Ⅰ-Ⅱ MALT Lymphoma
Role: collaborator
A Safety and Efficacy Trial of Chidamide Combined With NKG2D CAR-NK Cell Therapy for Reducing the HIV Viral Reservoir
Role: lead
PB-18 Probiotic for Mild to Moderate Depression
Role: lead
Hemorrhage Stroke Decision Making Model Based Deep Learning (BrainHemoAI System)
Role: collaborator
Prevention of AIDS With Opportunistic Infection Paradoxical IRIS
Role: collaborator
A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Sarcopenia With Silkworm Pupa Tablets in Patients With Malignancies
Role: lead